Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...

Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Full Year 2024 Results Key Financial Results Revenue: UK£31.4b (up 3.5% from FY 2023). Net ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

In June, 75 years of manufacturing history will come to an end in the town when pharmaceutical giant GSK closes its factory at Canal Foot. The history of the pharmaceutical industry in the town goes ...

A new global survey shows that 56.6% of Indian participants aged 50 and above know little to nothing about shingles, although ...

AI-powered tools like Merck’s Aiddison can accelerate drug identification and optimise design, cutting both costs and time to ...

Among those with chronic medical conditions, a third (33 percent) either had no concerns about developing shingles or were ...

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...

Hundreds of small plastic white bottles washed up on beaches from Falmouth to Weymouth are believed to have come from a ...